Sigrun Gleich

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Effective treatment of low-risk acute GVHD with itacitinib monotherapy”.

Effective treatment of low-risk acute GVHD with itacitinib monotherapy

Blood(2022)10.1182/blood.2022017442

N/A

0.915DataRank · unranked

44 citations

Alexandra Capellini, Amin Alousi, Monzr M. Al Malki, Hannah Choe, Zachariah DeFilipp +25 more

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Blood Advances(2023)10.1182/bloodadvances.2023009853

N/A

0.794DataRank · unranked

25 citations

Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra +32 more

The utility of biomarkers in acute GVHD prognostication

Blood Advances(2023)10.1182/bloodadvances.2023009929

N/A

0DataRank · unranked

18 citations

Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra +29 more

Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use

Blood Advances(2023)10.1182/bloodadvances.2022008480

N/A

0DataRank · unranked

10 citations

Markus Weber, Elisabeth Meedt, Sakhila Ghimire, Daniel Wolff, Matthias Edinger +19 more

Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis

Blood Advances(2024)10.1182/bloodadvances.2023012091

N/A

0DataRank · unranked

18 citations

Nikolaos Spyrou, Matthias Hoepting, Paibel Aguayo‐Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana +31 more

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Blood Advances(2024)10.1182/bloodadvances.2023011049

N/A

0DataRank · unranked

14 citations

Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, George Morales +33 more

A Day 14 Endpoint for Acute GVHD Clinical Trials

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.01.079

N/A

0DataRank · unranked

11 citations

Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +36 more

Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.08.019

N/A

0DataRank · unranked

2 citations

Muna Qayed, Aaron Etra, Ran Reshef, Richard Newcomb, Nicholas Yuhasz +29 more

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD

Blood Advances(2025)10.1182/bloodadvances.2025017116

N/A

0DataRank · unranked

7 citations

Joseph Portelli, Nikolaos Katsivelos, Ioannis Louloudis, Paibel Aguayo‐Hiraldo, Francis Ayuk +32 more

Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD

Blood Advances(2023)10.1182/bloodadvances.2023009885

N/A

0DataRank · unranked

42 citations

Nikolaos Spyrou, William J. Hogan, Francis Ayuk, Zachariah DeFilipp, Daniela Weber +31 more